Last reviewed · How we verify
NCT05220657: EXOMIC
Exploring the Relationship Between the Gut Microbiome, Physical Fitness Levels and Metabolic Responses to Exercise
trial testing Maximal incremental exercise test in Elite Cyclists in 50 participants. Completed in 23 November 2022.
26 October 2022
Quick facts
| Lead sponsor | University of Rennes 2 |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 20 January 2022 |
| Primary completion | 26 October 2022 |
| Estimated completion | 23 November 2022 |
| Sites | 1 location across France |
Drugs / interventions tested
- Maximal incremental exercise test
- Submaximal exercise test
Conditions studied
- Elite Cyclists — all drugs for Elite Cyclists →
- Elite Soccer Players — all drugs for Elite Soccer Players →
- Sedentary Behavior — all drugs for Sedentary Behavior →
Sponsor
University of Rennes 2
Who can join
Adults 18 to 30, male only, with Elite Cyclists or Elite Soccer Players. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Gut microbiota are all microorganisms including bacteria and microscopic eukaryotes that live in the digestive tracts of humans or mammals. During the last decade, some authors highlighted that a link exists between gut microbiota and sport performance. In this project, we hypothesize that gut microbiota is able to adapt to the energy needs of the body, really higher in top-level athletes or considerably lower in inactive individuals. In this context, this clinical study aims to characterize the bacterial metagenome of gut microbiota from populations located in a continuum from sedentary people to top-level athletes with high (i.e. soccer players), even very high energy needs (i.e. cyclists). The finality of this project is thus to determine if it exists some bacterial profile allowing to characterize, even to predict, the energy metabolism of an athlete and so the probability to be performant in competition.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05220657
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Maximal incremental exercise test
Trials testing the same drug.
- NCT07276464 — Characterization of the Gut Microbiota Signature According to Physical Fitness and Its Implications for Intestinal Healt · recruiting
- NCT05718752 — Characterization of the Plasma Metallomic Profile to Acute Exercise in Healthy Men and Women (METALEXO) · completed
Other University of Rennes 2 trials
Trials by the same sponsor.
- NCT07276464 — Characterization of the Gut Microbiota Signature According to Physical Fitness and Its Implications for Intestinal Healt · recruiting
- NCT06644053 — Exploring Locomotion Behavior of Chronic Non-Specific Low Back Pain (cNSLBP) Patients While Walking Through Apertures in · completed
- NCT05851118 — Locomotion Strategies of Low Back Pain Patients in a Dynamic Environment · unknown
- NCT05718752 — Characterization of the Plasma Metallomic Profile to Acute Exercise in Healthy Men and Women (METALEXO) · completed
- NCT05446454 — Validity of Activity Monitors to Study Walking · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05220657 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Rennes 2
- Last refreshed: 10 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05220657.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing